247AD201 CELIA – A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy, Safety, and Tolerability of BIIB080 in Subjects with Mild Cognitive Impairment Due to Alzheimer’s Disease or Mild Alzheimer’s Disease Dementia

MH-152 – Prospective, Open Label, Phase IV, Multicenter Clinical Trial to Evaluate the Feasibility and Value of Dynamic Contrast Enhancement (DCE) Imaging Using 0.1 mmol/kg MULTIHANCE in the Grading of Cerebral Gliomas

A randomized, two period, double-blind placebo-controlled and open label, multicenter extension study to determine the long-term safety and tolerbility of JNJ-54861911 in subjects in the early Alzheimer's Disease Spectrum

Identifizierung von funktionellen Biomarkern für Tinnitus und Hyperakusis im Tiermodell und Menschen